Compuestos de dosis fija en la prevención secundaria de la cardiopatía isquémica
Authors:
- Ginés SanzGSGinés Sanz
- 1 July 2011
- journal article
- abstracts
- Published by Elsevier in Revista Espanola de Cardiologia
- Vol. 64, 3-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countriesEuropean Journal of Preventive Cardiology, 2009
- The Year in AtherothrombosisJACC, 2009
- Compliance with Antihypertensive Therapy in the ElderlyAmerican Journal of Cardiovascular Drugs, 2008
- Low Priority of Cardiovascular and Chronic Diseases on the Global Health AgendaCirculation, 2007
- Fixed-Dose Combinations Improve Medication Compliance: A Meta-AnalysisThe American Journal of Medicine, 2007
- The availability and affordability of selected essential medicines for chronicl diseases in six low- and middle-income countriesBulletin of the World Health Organization, 2007
- Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trialsThe Lancet, 2006
- Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysisBMJ, 2005
- A strategy to reduce cardiovascular disease by more than 80%BMJ, 2003
- Two decades of progress in preventing vascular diseaseThe Lancet, 2002